Cipla Enters Into a Licensing Agreement With Gilead to Expand ...
MUMBAI, India, May 13, 2020 /PRNewswire-AsiaNet/ -- Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (and hereafter referred to as "Cipla") today announced that it has signed a non-exclusive licensing agreement with Gilead Sciences, Inc. for the manufacturing and distribution of the investigational medi...
Authors: LATEST ASIANET NEWS RELEASES